TP53 DNA binding domain mutational status and rituximabbased treatment are independent prognostic factors for pediatric Burkitt lymphoma patients stratification.

Gaia MartireFederica LovisaElisa CarraroDomenico RizzatoSimone CesaroRosa Maria MuraAnnalisa TondoCinzia BertolinFrancesca BoarettoLeonardo SalviatiAlessandra BiffiMarta PillonLara Mussolin

Published in: Haematologica (2024)

Keyphrases

prognostic factors
dna binding
end stage renal disease
newly diagnosed
ejection fraction
peritoneal dialysis
diffuse large b cell lymphoma
young adults
patient reported outcomes
smoking cessation